| [1] |
CHEN Xi, LI Yongjun.
Effects of Chinese patent medicine for activating blood circulation on cardiac repair after myocardial infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 680-688.
|
| [2] |
XU Jianfei, LIN Li.
Research progress in pharmacological and non-pharmacological treatments of hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 433-441.
|
| [3] |
YUAN Zhen, CHEN Bilian.
Review of bleeding events in clinical studies of clopidogrel
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 341-349.
|
| [4] |
XING Kai, GONG Jinyu, LUO Jianquan.
Advances on pharmacogenomics of diuretics-related adverse reactions
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 204-212.
|
| [5] |
DANG Xiangji, ZHOU Lin, WANG Yixuan, ZENG Lu.
Individualized antithrombotic therapy on one patient with chronic renal insufficiency
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 477-480.
|
| [6] |
PU Chun, TAO Qingsong, ZHU Xiang, QIN Mingming, WU Qiwen, FENG Gang.
Value of three cardiac markers in the early diagnosis of acute myocardial infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 82-86.
|
| [7] |
JIANG Peng-li, WU Jing, SUN He.
Association of cognitive decline, diabetes mellitus and cancer with statins use: gaining insight through the FDA pharmacovigilance database
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1132-1138.
|
| [8] |
WANG Pan, XIE Shan-shan, GUO Jian-jun, BU Hai-zhi, CHEN Xi-jing.
Research overview in absorption, distribution, metabolism and excretion of dihydropyridine calcium antagonists
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(8): 937-943.
|
| [9] |
WANG Zhen-shan, LI Ling, DENG Xiao-lan, LI Hui, YU Min, YAN Jin, CHEN Ben-mei, YANG Guo-ping, OU-YANG Dong-sheng.
LC-MS determination of terazosin in human plasma and application
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(5): 530-534.
|
| [10] |
ZHANG Hong-xia, WU Yong-jie, GAO Ming-tang.
Protective effects of DDPH on myocardial ischemia reperfusion injury in isolated rat hearts
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(2): 160-165.
|
| [11] |
WANG Zhan-qing, WANG Jin-ping, XU Jing-feng.
Isosorbide dinitrate induces late preconditioning against myocardial infarction in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(12): 1385-1388.
|
| [12] |
ZHU Shen-yin, ZHOU Yuan-da, DU Guan-hua.
Research progress of xanthine oxidoreductase in biological functions and its inhibitor development
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1081-1086.
|
| [13] |
XUE Hao, GAO Min, LIU Guo-shu, WANG Hai.
Effect of iptakalim hydrochloride on extracellular matrix of kidney in spontaneously hypertensive rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1122-1128.
|
| [14] |
WANG Zhan-qing, YING Xiang-yu, XU Jing-feng.
Advances in preclinical studies on combination therapy of myocardial ischemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 847-850.
|
| [15] |
YU Shuang, YU Li-mei, YUAN Mu, YU Hong, WU Qin, SHI Jin-shan.
Effect of naftopidil'ramification-BWYJ on benign prostatic hyperplasia in mice and rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 873-877.
|
